1. Home
  2. EVTL vs ENTX Comparison

EVTL vs ENTX Comparison

Compare EVTL & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

N/A

Current Price

$0.58

Market Cap

235.6M

Sector

Industrials

ML Signal

N/A

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

N/A

Current Price

$2.82

Market Cap

147.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVTL
ENTX
Founded
2016
2010
Country
United Kingdom
Israel
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
147.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
EVTL
ENTX
Price
$0.58
$2.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$12.70
$9.00
AVG Volume (30 Days)
4.6M
351.4K
Earning Date
03-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.22
Revenue
N/A
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.00
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.91
52 Week High
$7.35
$4.20

Technical Indicators

Market Signals
Indicator
EVTL
ENTX
Relative Strength Index (RSI) 28.40 43.58
Support Level N/A $1.48
Resistance Level $1.42 $2.78
Average True Range (ATR) 0.05 0.20
MACD 0.02 -0.06
Stochastic Oscillator 23.91 1.33

Price Performance

Historical Comparison
EVTL
ENTX

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: